Complement component 3 and its activation split-products in saliva associate with periodontitis

J Periodontol. 2022 Sep;93(9):1294-1301. doi: 10.1002/JPER.21-0530. Epub 2022 Apr 1.

Abstract

Background: Periodontitis (PD) is classified by Grades A through C according to the risk of further progression, PD Grade C (PD-C) being the most severe progressing form. It is a matter of controversy, whether the disease activity observed in PD-C is due to impaired immune reactivity toward bacteria embedded in biofilms or a hyper-reactive immune response causing tissue damage as a bystander phenomenon. Little is known about the role of complement in this respect.

Methods: Plasma and unstimulated saliva samples were collected from patients with PD-B (n = 34) or -C (n = 27) and healthy controls (HCs) (n = 28). Salivary and plasma levels of total C3, C3c, and C3dg were quantified using sandwich enzyme-linked immunosorbent assay (ELISA).

Results: Salivary levels of total C3 and C3dg were elevated in PD-B and PD-C patients compared to HCs (both P < 0.05), while the levels of C3c were elevated in PD-C compared to HCs. Plasma levels of C3c were higher in PD-B patients than in HCs (P < 0.05).

Conclusion: PD-B and PD-C patients show increased complement activation compared to HCs, but no difference was found between the two disease grades. PD-B, but not PD-C, is associated with increased systemic complement activation as assessed by C3c in plasma.

Keywords: complement component 3; immunology; inflammation and innate immunity; pathogenesis; periodontitis; saliva.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Complement C3* / analysis
  • Complement C3c
  • Enzyme-Linked Immunosorbent Assay / methods
  • Humans
  • Periodontitis*
  • Saliva / chemistry

Substances

  • Complement C3
  • Complement C3c